Latest News about SNY
Recent news which mentions SNY
After Five Years Of Collaboration, Sanofi & Innate Pharma Expand Oncology Pact With Additional Programs
December 19, 2022
From Benzinga
2 Best Biotech Stocks to Buy Right Now
December 16, 2022
From Motley Fool
Regeneron-Sanofi's Dupixent Wins European Approval For Prurigo Nodularis
December 15, 2022
From Benzinga
These Biotech Stocks Are the Nasdaq's Big Wednesday Winners
December 14, 2022
From Motley Fool
Why Is Kymera Therapeutics (KYMR) Stock Up 20% Today?
December 14, 2022
From InvestorPlace
From Benzinga
Horizon Therapeutics (HZNP) Stock Pops on HUGE Amgen Deal
December 12, 2022
From InvestorPlace
From Benzinga
Two Down With Sanofi Bowing Out From Horizon Buyout Talks, Amgen Agrees To Buy For $116.5/Share
December 12, 2022
From Benzinga
Amgen reportedly in talks to buy Horizon Therapeutics
December 12, 2022
From MarketWatch
Will This Potential Approval Be a Winner for Sanofi's Shareholders?
December 09, 2022
From Motley Fool
France Health Body Advises Unfavorable Opinion Regarding Valneva's COVID-19 Vaccine
December 08, 2022
From Benzinga
This Monster Dividend Stock Isn't Done Growing
December 08, 2022
From Motley Fool
Revolution Medicines Regains Global Rights To Mid-Stage Cancer Program As Sanofi Terminates Collaboration
December 08, 2022
From Benzinga
Fusion Fuel (HTOO) Stock Is Up 11% on HUGE Deal News
December 07, 2022
From InvestorPlace
Why Is TransCode Therapeutics (RNAZ) Stock Up 148% Today?
December 07, 2022
From InvestorPlace
SNY Stock Alert: Why 1 Analyst Says Zantac Ruling Is ‘Best-Case Scenario’ for Drugmakers
December 07, 2022
From InvestorPlace
From Benzinga
From Benzinga
GSK and Sanofi shares surge after Florida ruling dismisses Zantac lawsuits in what one analyst describes as ‘best-case scenario’
December 07, 2022
From MarketWatch
These 3 Stocks Escaped Tuesday's Market Downdraft
December 06, 2022
From Motley Fool
Why GSK Plc And Sanofi SA Stock Are Shooting Higher
December 06, 2022
From Benzinga
From Benzinga
The S&P 500 is on the cusp of breaking through a level that might spell the end of the bear market
December 01, 2022
From MarketWatch
Why Horizon Therapeutics Stock Is Skyrocketing Today
November 30, 2022
From Motley Fool
Why Is Horizon Therapeutics (HZNP) Stock Up 30% Today?
November 30, 2022
From InvestorPlace
From Motley Fool
UK Drug Regulator Warns Of Severe Eye Reactions Associated With Sanofi/Regeneron's Dupixent
November 30, 2022
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.